Healthcare & Insurance
Adamis Pharmaceuticals Announces Publication of Comparative Pharmacokinetics of Community Use Naloxone Formulations
SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today that an article entitled “Comparative Pharmacokinetic Analysis of Community Use Naloxone Formulations for Acute Treatment of Opioid Overdose” was accepted for
Monday, November 18, 2019
Prevail Therapeutics Announces Appointment of Morgan Sheng, Ph.D., to Board of Directors
NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced the appointment of Morgan Sheng, Ph.D., to its Board of
Monday, November 18, 2019
Quotient Limited to Participate in the Jefferies 2019 London Healthcare Conference
JERSEY, Channel Islands, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company’s Chief Executive Officer, Franz Walt, the Company’s President of R&D and Manufacturing, Ed Farrell, and the
Monday, November 18, 2019
New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or
THOUSAND OAKS, Calif. and SOUTH SAN FRANCISCO, Calif. and SURESNES, France,, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Amgen (NASDAQ: AMGN), Cytokinetics, Incorporated (NASDAQ: CYTK) and Servier announced that new results from COSMIC-HF (Chronic Oral Study of Myosin Activation
Monday, November 18, 2019
Cannabix Technologies Reaches Development Milestone with Marijuana Breathalyzer Devices – Provides New Pictures
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyVANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana
Monday, November 18, 2019
Acasti Pharma Releases Preliminary New Animal Data, and Gains Insights Into CaPre’s Novel Mechanism of Action in Diabetes
Data from a new preclinical mouse study suggests a unique mechanism of CaPre compared to metformin and icosapent ethyl (VASCEPA®) in a diet-induced obesity animal model Preliminary, statistically significant findings show that CaPre may promote insulin secretion, and showed a significant increase
Monday, November 18, 2019
Transactions under Novozymes’ stock buyback program
Please read the full announcement in the attached PDF Attachment 2019_51_Stock_Buybackprogram_EN
Monday, November 18, 2019
Artelo Biosciences Announces Publication of Positive Non-Clinical Fatty Acid Binding Protein 5 Inhibitor Data in Peer-Reviewed Journal
Combination of FABP5 inhibitors with taxanes resulted in complete prostate cell death demonstrating more efficacious antitumor activity and more limited side‐effects than standard-of-care taxane therapy aloneLA JOLLA, Calif., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ:
Monday, November 18, 2019
Freedom Leaf Announces Closing of a $5 Million Round of Growth Capital
Financing supports the evolution of the Company into a leading CBD Hemp player in North AmericaDALLAS, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Freedom Leaf, Inc. (“Freedom Leaf” or the “Company”) (OTCQB: FRLF), a first in class hemp consumer packaged goods company that recently acquired Green
Monday, November 18, 2019
Ontario Pharmacists and Avricore Health Partner to Expand HealthTab™ in Community Pharmacies and Enhance Patient Care
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are pleased to announce a Memorandum of Understanding (MOU) to offer in partnership the
Monday, November 18, 2019
Enlivex Therapeutics Completes Recruitment In Phase Ib Trial Evaluating Safety And Efficacy Of Universal Off-The-Shelf Allocetra In Patients With
Nes Ziona, Israel, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today reported completion of patient recruitment into the Company’s Phase Ib clinical trial in patients with severe sepsis. The study was designed to recruit
Monday, November 18, 2019
One World Pharma Uplists to the OTCQB
LAS VEGAS, NV, Nov. 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – One World Pharma Inc. (OTC: OWPC), “OWP,” a fully licensed pure-play cannabis and hemp ingredient producer in Colombia, is pleased to announce that its common stock has been uplisted to the OTCQB platform, effective
Monday, November 18, 2019
RenovaCare Appoints Alan L. Rubino as President and CEO
SCOTTSDALE, Ariz., Nov. 18, 2019 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration of tissues and organs, today announced the appointment of Alan L. Rubino as President and
Monday, November 18, 2019
ECMOHO to Report Third Quarter 2019 Unaudited Financial Results on November 25, 2019
SHANGHAI, China, Nov. 18, 2019 (GLOBE NEWSWIRE) -- ECMOHO Limited (Nasdaq: MOHO) ("ECMOHO" or the "Company"), a leading integrated solutions provider in the rapidly growing non-medical health and wellness market in China, today announced that it will report its unaudited financial results for the
Monday, November 18, 2019
CooperCompanies Announces CooperVision Has Received FDA Approval of MiSight® for the Treatment of Myopia in Children
Becomes the First and Only FDA Approved Contact Lens of its Kind in the U.S.SAN RAMON, Calif., Nov. 18, 2019 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), announced today that CooperVision has received U.S. Food and Drug Administration (FDA) approval of its MiSight® 1 day contact lens1,
Monday, November 18, 2019
Pillar Marketing Group, Inc., Announces Acquisition Purchase of Controlling interest in Select-TV Solutions, Inc., Changing their name to BioQuest
Newport Beach, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioQuest Corp, (BQST or the “COMPANY”) (OTC:BQST), (the temporary symbol on 11/15/2019 is SELTD. Please note that a “D” has been appended as the 5th character for 20 business days including the effective date. After 20 business days the
Monday, November 18, 2019
Celldex Initiates Phase 1 Study of KIT Inhibitor CDX-0159
CDX-0159 to be studied in chronic idiopathic urticaria after completing healthy volunteer studyHAMPTON, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that a Phase 1a study of CDX-0159 has initiated in healthy volunteers. CDX-0159 is a humanized
Monday, November 18, 2019
Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Racemic Ketamine (SLS-002)
NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced the U.S. Food and Drug Administration (FDA) has granted
Monday, November 18, 2019
iCAD to Participate at the Cannacord Genuity Medtech & Diagnostics Forum
NASHUA, N.H., Nov. 18, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will present a corporate overview at the Canaccord
Monday, November 18, 2019
TRHC Announces the Execution of a Pharmacy Services Agreement with WelbeHealth
The partnership with WelbeHealth demonstrates TRHC’s commitment to help grow PACE organizations in California and nationwideMOORESTOWN, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication
Monday, November 18, 2019
